BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 33493)

  • 1. [The angina pectoris syndrome. II. Therapeutic principles].
    Wandner V
    Z Arztl Fortbild (Jena); 1979 Jan; 73(2):58-62. PubMed ID: 33493
    [No Abstract]   [Full Text] [Related]  

  • 2. Therapeutics of angina.
    Fancourt GJ; Matts SG
    Br J Clin Pract; 1982 Jun; 36(6):217-21. PubMed ID: 6128993
    [No Abstract]   [Full Text] [Related]  

  • 3. [Therapy of angina pectoris].
    Michel D
    ZFA (Stuttgart); 1977 Jan; 53(1):25-32. PubMed ID: 14449
    [No Abstract]   [Full Text] [Related]  

  • 4. [Newer aspects in the therapy of angina pectoris].
    Zölch KA; Kleinfelder H
    Fortschr Med; 1976 Aug; 94(24):1261-6. PubMed ID: 9345
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Antianginal drugs].
    Kugiyama K; Yasue H
    Nihon Rinsho; 1994 Jul; 52 Suppl(Pt 1):1051-8. PubMed ID: 12436657
    [No Abstract]   [Full Text] [Related]  

  • 6. Antianginal drugs.
    Kaverina NV; Chumburidze VB
    Pharmacol Ther; 1979; 4(1):109-53. PubMed ID: 88742
    [No Abstract]   [Full Text] [Related]  

  • 7. [Problems of combined therapy with cardiac glycosides and anti-anginal drugs (author's transl)].
    Klaus W
    Arzneimittelforschung; 1977; 27(3a):731-6. PubMed ID: 17417
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [So-called coronary drugs].
    Gamski M
    Kardiol Pol; 1982; 25(2):163-8. PubMed ID: 6125622
    [No Abstract]   [Full Text] [Related]  

  • 9. Drugs for angina pectoris.
    Drug Ther Bull; 1974 Jan; 12(1):1-2. PubMed ID: 4150248
    [No Abstract]   [Full Text] [Related]  

  • 10. [Development of pharmacologic criteria for development of antianginal medications].
    Charlier R
    Brux Med; 1969 Sep; 49(9):543-60. PubMed ID: 4391538
    [No Abstract]   [Full Text] [Related]  

  • 11. [Treatment of the intermediate syndrome].
    Mady C; Macruz R
    Arq Bras Cardiol; 1979 Feb; 32(2):71-4. PubMed ID: 37821
    [No Abstract]   [Full Text] [Related]  

  • 12. [Classification of anti-angina drugs].
    Schmitt H; Laubie M
    Therapie; 1970; 25(2):199-208. PubMed ID: 4403155
    [No Abstract]   [Full Text] [Related]  

  • 13. [Coronary drugs: facts and assumptions (author's transl)].
    Jasiński K
    Przegl Lek; 1975; 32(7):573-9. PubMed ID: 240191
    [No Abstract]   [Full Text] [Related]  

  • 14. [Clinical aspects of the classification of anti-angina drugs].
    Chiche P
    Therapie; 1970; 25(2):213-24. PubMed ID: 4403156
    [No Abstract]   [Full Text] [Related]  

  • 15. [Therapeutic measures in angina pectoris vera].
    Klepzig H
    Med Klin; 1974 Apr; 69(14):574-6. PubMed ID: 4151738
    [No Abstract]   [Full Text] [Related]  

  • 16. Medical therapy for stable angina.
    Gazewood JD
    J Fam Pract; 1999 Sep; 48(9):660-1. PubMed ID: 10498064
    [No Abstract]   [Full Text] [Related]  

  • 17. [Therapy using beta-receptor blockaders in coronary disease].
    Bolte HD
    Internist (Berl); 1978 Sep; 19(9):520-6. PubMed ID: 29850
    [No Abstract]   [Full Text] [Related]  

  • 18. Drugs for stable angina pectoris.
    Med Lett Drugs Ther; 1994 Dec; 36(937):111-4. PubMed ID: 7968785
    [No Abstract]   [Full Text] [Related]  

  • 19. [Nitroglycerin and beta blockers: the only current drugs in angina pectoris. Report of the information booklet from the Swedish Social Governmental Agency "Drugs in angina pectoris" 1971 part 2:I and 2:II].
    Lund-Larsen PG
    Tidsskr Nor Laegeforen; 1973 Jun; 93(18):1405. PubMed ID: 4148048
    [No Abstract]   [Full Text] [Related]  

  • 20. [Actual and theoretical points of view in the application of coronary therapeutic agents].
    Döring D
    Z Gesamte Inn Med; 1980 Jun; 35(11):475-81. PubMed ID: 6108022
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.